ATE331037T1 - Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff - Google Patents
Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoffInfo
- Publication number
- ATE331037T1 ATE331037T1 AT96912605T AT96912605T ATE331037T1 AT E331037 T1 ATE331037 T1 AT E331037T1 AT 96912605 T AT96912605 T AT 96912605T AT 96912605 T AT96912605 T AT 96912605T AT E331037 T1 ATE331037 T1 AT E331037T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- frpb
- acid molecule
- isolated
- corresponding vaccine
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 150000007523 nucleic acids Chemical class 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 235000018102 proteins Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 abstract 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41896495A | 1995-04-07 | 1995-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE331037T1 true ATE331037T1 (de) | 2006-07-15 |
Family
ID=23660253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96912605T ATE331037T1 (de) | 1995-04-07 | 1996-04-08 | Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff |
Country Status (8)
Country | Link |
---|---|
US (3) | US6265567B1 (de) |
EP (1) | EP0830456B1 (de) |
JP (1) | JP3797490B2 (de) |
AT (1) | ATE331037T1 (de) |
AU (1) | AU5537096A (de) |
CA (1) | CA2217522C (de) |
DE (1) | DE69636285D1 (de) |
WO (1) | WO1996031618A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265567B1 (en) * | 1995-04-07 | 2001-07-24 | University Of North Carolina At Chapel Hill | Isolated FrpB nucleic acid molecule |
US6914131B1 (en) | 1998-10-09 | 2005-07-05 | Chiron S.R.L. | Neisserial antigens |
CA2308606A1 (en) * | 1997-11-06 | 1999-05-20 | Chiron S.P.A. | Neisserial antigens |
GB9808866D0 (en) * | 1998-04-24 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
AU3968599A (en) * | 1998-04-29 | 1999-11-16 | American Cyanamid Company | Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis |
AU761780B2 (en) * | 1998-05-01 | 2003-06-12 | Glaxosmithkline Biologicals Sa | Neisseria meningitidis antigens and compositions |
GB9810276D0 (en) * | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
US6692752B1 (en) | 1999-09-08 | 2004-02-17 | Smithkline Beecham Biologicals S.A. | Methods of treating human females susceptible to HSV infection |
EP1144643A1 (de) * | 1999-01-15 | 2001-10-17 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Neisseria meningitidis antigen |
GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
AU784203B2 (en) * | 1999-10-29 | 2006-02-23 | Glaxosmithkline Biologicals S.A. | Neisserial antigenic peptides |
JP4763210B2 (ja) | 2000-02-28 | 2011-08-31 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | ナイセリアのタンパク質の異種発現 |
GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
EP2255826B1 (de) | 2002-08-02 | 2016-04-13 | GlaxoSmithKline Biologicals S.A. | Neisseria impfstoffzusammensetzungen die eine kombination von antigenen enthalten |
GB0220199D0 (en) * | 2002-08-30 | 2002-10-09 | Univ Utrecht | Mutant protein and refolding method |
LT2395073T (lt) | 2002-11-01 | 2017-11-10 | Glaxosmithkline Biologicals S.A. | Džiovinimo būdas |
GB2414667A (en) * | 2004-06-03 | 2005-12-07 | Isis Innovation | Vaccine compositions of N. meningitidis PorA and FetA antigens |
GB0505996D0 (en) | 2005-03-23 | 2005-04-27 | Glaxosmithkline Biolog Sa | Fermentation process |
JP5275983B2 (ja) | 2006-06-12 | 2013-08-28 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265567B1 (en) * | 1995-04-07 | 2001-07-24 | University Of North Carolina At Chapel Hill | Isolated FrpB nucleic acid molecule |
-
1996
- 1996-04-05 US US08/628,434 patent/US6265567B1/en not_active Expired - Lifetime
- 1996-04-08 EP EP96912605A patent/EP0830456B1/de not_active Expired - Lifetime
- 1996-04-08 DE DE69636285T patent/DE69636285D1/de not_active Expired - Lifetime
- 1996-04-08 AT AT96912605T patent/ATE331037T1/de not_active IP Right Cessation
- 1996-04-08 AU AU55370/96A patent/AU5537096A/en not_active Abandoned
- 1996-04-08 JP JP53052996A patent/JP3797490B2/ja not_active Expired - Lifetime
- 1996-04-08 CA CA2217522A patent/CA2217522C/en not_active Expired - Lifetime
- 1996-04-08 WO PCT/US1996/004774 patent/WO1996031618A1/en active IP Right Grant
-
2001
- 2001-03-08 US US09/801,451 patent/US20030096368A1/en not_active Abandoned
-
2005
- 2005-07-26 US US11/190,799 patent/US20050271681A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU5537096A (en) | 1996-10-23 |
DE69636285D1 (de) | 2006-08-03 |
US6265567B1 (en) | 2001-07-24 |
EP0830456A1 (de) | 1998-03-25 |
US20030096368A1 (en) | 2003-05-22 |
JP3797490B2 (ja) | 2006-07-19 |
CA2217522A1 (en) | 1996-10-10 |
WO1996031618A1 (en) | 1996-10-10 |
EP0830456B1 (de) | 2006-06-21 |
JPH11503322A (ja) | 1999-03-26 |
CA2217522C (en) | 2011-09-20 |
US20050271681A1 (en) | 2005-12-08 |
EP0830456A4 (de) | 2001-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69636285D1 (de) | ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF | |
DK0758248T3 (da) | Formuleringer til faktor IX | |
DE69620877D1 (de) | Arzneimittelformulierungen für il-12 | |
NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
TR200101867T2 (tr) | CCR5 modülatörleri olarak piperidinler | |
NO983999D0 (no) | Peptidimmunogener for vaksinasjon mot og behandling av allergi | |
DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
TR200806259T2 (tr) | Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler | |
NO990405L (no) | Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler | |
DE69610627D1 (de) | Neuartige peptidderivate | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
CY1105235T1 (el) | Συνθεσεις λασοφοξιφενης | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
ATE210988T1 (de) | Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen | |
DE69331739D1 (de) | Neuartige pharmazeutische verwendungen von krill-enzymen | |
ATE203519T1 (de) | Chinolinderivate als antimalariamittel | |
PT789590E (pt) | Imunopotenciacao induzida por quitosano | |
HUP0202729A2 (hu) | Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények | |
AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
ATE201693T1 (de) | Hämoregulierende peptide | |
AU5163598A (en) | Novel hepatitis b inhibitors | |
DE69619123D1 (de) | Hämoregulatorische verbindungen | |
DK0579765T3 (da) | Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme | |
ATE204286T1 (de) | Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |